corilagin has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Hwang, ST; Kumar, AP; Sethi, G; Yang, MH | 1 |
| Elendran, S; Lee, WW; Muniyandy, S; Palanisamy, UD | 1 |
2 other study(ies) available for corilagin and Colonic Neoplasms
| Article | Year |
|---|---|
Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade.
Topics: Cadherins; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Glucosides; Humans; Hydrolyzable Tannins; Male; MCF-7 Cells; Neoplasm Invasiveness; Neoplasm Proteins; Occludin; Prostatic Neoplasms; Transforming Growth Factor beta; Wnt Signaling Pathway | 2020 |
Permeability of the ellagitannin geraniin and its metabolites in a human colon adenocarcinoma Caco-2 cell culture model.
Topics: Adenocarcinoma; Biological Transport; Caco-2 Cells; Cell Survival; Colonic Neoplasms; Ellagic Acid; Gallic Acid; Glucosides; Humans; Hydrolyzable Tannins; Molecular Structure; Permeability | 2019 |